Tevogen Bio Holdings Inc. (TVGN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 54.98M |
| Enterprise Value | 57.53M |
| P/E Ratio | -0.96 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -2.41 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.2 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -4.57 |
| Return On Equity | 2.48 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -25.57M |
| Net Income | -26.28M |
| Diluted EPS | -8.08 |
Balance Sheet
| Total Cash | 1.08M |
| Total Cash/Share | 0.28 |
| Total Debt | 3.04M |
| Total Debt/Equity | -0.34 |
| Current Ratio | 0.33 |
| Book Value Per Share | -2.32 |
Price History
| 52-Week Change | -80.99 |
| 52-Week High | 32.5 |
| 52-Week Low | 3.64 |
| Moving Average 50 Days | 6.97 |
| Moving Average 200 Days | 8.19 |
Statistics
| Average Volume | 8,410 |
| Shares Outstanding | 4.16M |
| % Held by Institutions | 2.82 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | March 06, 2026 |
AD
